Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Cancer Research

• Publication date

  1983-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 6407752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polyamines in Mammalian Biology and Medicine

  2015cited by this paper
• The difference between the effects of single and double applications of 12-O-tetradecanoylphorbol-13-acetate, a potent tumor promoter, on polyamine metabolism and nucleic acid synthesis in mouse epidermis.

  1983cited by this paper
• Polyamine metabolism and function.

  1982cited by this paper
• Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine.

  1982cited by this paper
• alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.

  1982cited by this paper
• Role of polyamines in the control of cell proliferation and differentiation.

  1981cited by this paper
• Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells.

  1981cited by this paper
• Effects of parathyroid hormone and cyclic AMP analogues on the activity of ornithine decarboxylase and expression of the differentiated phenotype of chondrocytes in culture

  1981cited by this paper
• Promotion of carcinomas by repeated abrasion in initiated skin of mice.

  1981cited by this paper
• Role of polyamines in expression of the differentiated phenotype of chondrocytes in culture.

  1981cited by this paper
• Antitumor effects of vitamin A and inhibitors of ornithine decarboxylase in cultured neuroblastoma and glioma cells.

  1980cited by this paper
• Polyamine and differentiation: induction of ornithine decarboxylase by parathyroid hormone is a good marker of differentiated chondrocytes.

  1980cited by this paper
• Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

  1980cited by this paper
• Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo.

  1979cited by this paper
• Inhibition of phorbol ester-induced tumor promotion in mice by vitamin A analog and anti-inflammatory steroid.

  1979cited by this paper
• Tumor promotion and the induction of epidermal ornithine decarboxylase activity in mechanically stimulated mouse skin.

  1978cited by this paper
• Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor.

  1977cited by this paper
• The role of putrescine in cell proliferation of the skin of mice induced by ethylphenylpropriolate.

  1977cited by this paper
• The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis.

  1976cited by this paper
• Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis.

  1971cited by this paper

• Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks.

  2023cites this paper
• The Role of Biogenic Amines in Nutrition Toxicology: Review

  2020cites this paper
• Structure based design of inhibitory peptides targeting ornithine decarboxylase dimeric interface and in vitro validation in human retinoblastoma Y79 cells

  2020cites this paper
• Investigational drugs currently in phase II clinical trials for actinic keratosis

  2019cites this paper
• Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.

  2018cites this paper
• Chemical Carcinogenesis Models of Cancer: Back to the Future

  2017cites this paper
• Kinase and Phosphatase Effector Pathways in T Cells

  2016cites this paper
• Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines

  2015cites this paper
• ASSESSING THE ROLE OF DIETARY POLYAMINES ON THE CONTINUUM OF COLORECTAL CARCINOMA

  2013cites this paper
• Nonmelanoma Skin Cancer Chemoprevention

  2011cites this paper
• Polyamines and hair: a couple in search of perfection

  2010cites this paper
• The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.

  2008cites this paper
• Effect of difluoromethylornithine on chromosomes in living organisms and in tissue culture cells.

  2008cites this paper
• Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion‐sensitive and promotion‐resistant genetic backgrounds

  2007cites this paper
• Polyamines and nonmelanoma skin cancer.

  2007cites this paper
• Combination-Fluoro-5-androsten-17-one , and Ellagic Acid Individually and in α-Difluoromethylornithine , 16 α Administration of Piroxicam , Chemoprevention of Colon Carcinogenesis by Dietary Updated

  2006cites this paper
• Role of Ornithine Decarboxylase in Epidermal Tumorigenesis 1

  2006cites this paper
• Difluoromethylornithine during and after Carcinogen Treatment Chemoprevention of Mouse Colon Tumors with Updated

  2006cites this paper
• Carcinogenesis Protein Kinase C , Inhibits Promotional Phase in Mouse Skin Isoform of η Cholesterol Sulfate , a Second Messenger for the Updated

  2006cites this paper
• Chemoprevention of nonmelanoma skin cancer.

  2006cites this paper
• The cell clone ecology hypothesis and the cell fusion model of cancer progression and metastasis (II): three pathways for spontaneous cell-cell fusion and escape from the intercellular matrix.

  2006cites this paper
• α‐Difluoromethylornithine, a polyamine inhibitor: its potential role in controlling hair growth and in cancer treatment and chemo‐prevention

  2006cites this paper
• Perspectives in Cancer Research Chemoprevention of Cancer

  2006cites this paper
• Chemoprevention of Chemical Carcinogenesis and Human Cancer

  2005cites this paper
• Haploinsufficiency for odc modifies mouse skin tumor susceptibility.

  2005cites this paper
• Suprabasal induction of ornithine decarboxylase in adult mouse skin is sufficient to activate keratinocytes.

  2005cites this paper
• Clinical development plan: 2‐Difluoromethylornithine (DFMO)

  2004cites this paper
• Polyamines and cancer: Minireview article

  2004cites this paper
• Skin cancer chemoprevention: strategies to save our skin.

  2003cites this paper
• Ornithine Decarboxylase Activity in Tissues from Rats Exposed to 60 Hz Magnetic Fields, Including Harmonic and Transient Field Characteristics

  2003cites this paper
• Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors.

  2003cites this paper
• Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.

  2003cites this paper
• Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.

  2003cites this paper
• Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.

  2002cites this paper
• Chemoprevention of human skin cancer.

  2002cites this paper
• The difference in the stimulation by putrescine of DNA synthesis using DNA polymerase extracts of normal rat liver or of tumour tissue or host liver from tumour‐bearing rats

  2002cites this paper
• Induction of epithelial differentiation and DNA demethylation in hamster malignant oral keratinocyte by ornithine decarboxylase antizyme

  2001cites this paper
• Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N-acetyltransferase.

  2001cites this paper
• Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice.

  2001cites this paper
• Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice

  2000cites this paper
• Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.

  2000cites this paper
• Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine.

  2000cites this paper
• Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.

  2000cites this paper
• K6/ODC transgenic mice as a sensitive model for carcinogen identification.

  2000cites this paper
• Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.

  1999cites this paper
• Dynamic expression of ornithine decarboxylase in hair growth.

  1999cites this paper
• Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.

  1999cites this paper
• Low-dose difluoromethylornithine and polyamine levels in human prostate tissue.

  1999cites this paper
• Developmental toxicity studies of 2-(difluoromethyl)-dl-ornithine (DFMO) in rats and rabbits.

  1999cites this paper
• Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.

  1999cites this paper
• Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.

  1998cites this paper
• Occupational applications of a human cancer research model.

  1998cites this paper
• Phase I Chemoprevention Study of Piroxicam and rn

  1998cites this paper
• Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.

  1998cites this paper
• Vitamin E: the radical protector

  1998cites this paper
• Polyamine metabolism as target for cancer chemoprevention (review).

  1998cites this paper
• Perspectives in cancer chemoprevention.

  1997cites this paper
• Chemopreventive effect of difluoromethylornithine (DMFO) on mouse skin squamous cell carcinomas induced by Benzo(a)pyrene

  1997cites this paper
• Additional considerations about the bioeffects of mobile communications

  1997cites this paper
• Failure of dietary alpha-difluoromethylornithine to inhibit gastric carcinogenesis in rats after 8 weeks of treatment with N-methyl-N'-nitro-N-nitrosoguanidine and sodium chloride.

  1997cites this paper
• Failure of dietary α-difluoromethylornithine to inhibit gastric carcinogenesis in rats after 8 weeks of treatment with N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride

  1997cites this paper
• Chemoprevention of gastrointestinal cancer

  1997cites this paper
• Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity.

  1996cites this paper
• Experimental transmission of epidermal lip papillomas in white sucker, Catostomus commersoni

  1996cites this paper
• Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.

  1996cites this paper
• Chemoprevention of cancer.

  1996cites this paper
• Nutrition and carcinogenesis: historical highlights and future prospects.

  1995cites this paper
• Concepts in multistage carcinogenesis.

  1995cites this paper
• Relationship between ornithine decarboxylase and cytoskeletal organization in cultured human keratinocytes: cellular responses to phorbol esters, cytochalasins, and alpha-difluoromethylornithine.

  1995cites this paper
• Inhibition of Chemical Carcinogenesis

  1995cites this paper
• Role of ornithine decarboxylase in epidermal tumorigenesis.

  1995cites this paper
• Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.

  1995cites this paper
• Chronic toxicity studies of the potential cancer preventive 2-(difluoromethyl)-dl-ornithine.

  1994cites this paper
• Biosynthesis and selective export of 1,5-diaminopentane (cadaverine) in mycoplasma-free cultured mammalian cells.

  1994cites this paper
• Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.

  1994cites this paper
• Chemoprevention of respiratory-tract neoplasia in the hamster by oltipraz, alone and in combination.

  1994cites this paper
• Chemopreventive drug development: perspectives and progress.

  1994cites this paper
• Clinical development plan: 2-difluoromethylornithine (DFMO).

  1994cites this paper
• Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.

  1993cites this paper
• Cancer chemoprevention: principles and prospects.

  1993cites this paper
• Chemoprevention of oral carcinogenesis by DL-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats.

  1993cites this paper
• Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.

  1993cites this paper
• Inhibition of chemical carcinogenesis

  1993cites this paper
• Antitumor-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin.

  1992cites this paper
• Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate.

  1992cites this paper
• A propspective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer

  1992cites this paper
• Chemoprevention in prostate cancer: The role of difluoromethylornithine (DFMO)

  1992cites this paper
• Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene.

  1992cites this paper
• [Specific induction by phorbol ester of the gene transcription and of the activity of ornithine decarboxylase in two control and transformed epithelial cell lines. Modulator effect of anti-inflammatory agents].

  1992cites this paper
• Status of ornithine decarboxylase activity and DNA synthesis in mancozeb-exposed mouse skin.

  1992cites this paper
• Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo.

  1991cites this paper
• Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.

  1991cites this paper
• Dose-related alpha-difluoromethylornithine ototoxicity.

  1991cites this paper
• Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas.

  1991cites this paper
• Chemoprevention of Colon Carcinogenesis by Dietary Administration of Piroxicam, α-Difluoromethylornithine, 16α-Fluoro-5-androsten-17-one, and Ellagic Acid Individually and in Combination

  1991cites this paper
• Inhibition of chemically-induced skin carcinogenesis in mice by peanut oil preparations.

  1991cites this paper
• Study of postnatal effects of chemopreventive agents on offspring of ethylnitrosourea-induced transplacental carcinogenesis in rats. I. Influence of retinol acetate, alpha-tocopherol acetate, thiamine chloride, sodium selenite, and alpha-difluoromethylornithine.

  1991cites this paper
• Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse.

  1991cites this paper
• Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation.

  1991cites this paper
• Polyamines: from molecular biology to clinical applications.

  1991cites this paper